Karuna Therapeutics, Inc. (KRTX) Financials

Stock symbol KRTX is outdated, potentially delisted? Maybe it is available on other exchange?

KRTX Assets vs Liabilities

Date	Assets	Liabilities
Dec. 31, 2023	1.3 billion	82.0 million
Sept. 30, 2023	1.4 billion	62.8 million
June 30, 2023	1.5 billion	52.5 million
March 31, 2023	1.5 billion	28.0 million

KRTX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Dec. 31, 2023	-111.9 million	22.8 million
Sept. 30, 2023	-110.6 million	18.3 million
June 30, 2023	-64.9 million	18.0 million
March 31, 2023	-101.3 million	15.5 million

KRTX Net Income

No data available :(

KRTX Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Dec. 31, 2023	1.3 billion	13.8 million	16.7 million
Sept. 30, 2023	1.3 billion	13.8 million	15.6 million
June 30, 2023	1.4 billion	13.8 million	15.8 million
March 31, 2023	1.5 billion	2.7 million	4.8 million

KRTX Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Dec. 31, 2023	37.8 million
Sept. 30, 2023	37.7 million
June 30, 2023	37.5 million
March 31, 2023	34.8 million

KRTX Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Dec. 31, 2023	799000	82.2 million	47.4 million	-
Sept. 30, 2023	629000	104.0 million	32.3 million	-
June 30, 2023	775000	92.5 million	27.4 million	-
March 31, 2023	714000	85.5 million	24.3 million	-

KRTX Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Dec. 31, 2023	-	447000
Sept. 30, 2023	-	458000
June 30, 2023	-	469000
March 31, 2023	654000	327000

KRTX

Price: $329.83

52 week price:

158.38

329.99

Earnings Per Share: -10.94 USD

P/E Ratio: -29.07

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 180800

Market Capitalization: 12.6 billion

Links:

KRTX on Yahoo Finance